Cynomolgus IGFBP2 Protein (IGF-CM102)
$283.50 – $945.00
KACTUS Biosystems Cynomolgus IGFBP2 Protein (IGF-CM102) (catalog No. IGF-CM102) is expressed from HEK293 with His tag at the C-Terminus.It contains Gly33-Gln325.
- Details & Specifications
- References
- More Offers
| Catalog No. | IGF-CM102 |
|---|---|
| Product Name | Cynomolgus IGFBP2 Protein (IGF-CM102) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Species | Cynomolgus |
| Source | HEK293 |
| Accession | A0A2K5WZA2 |
| Product Tag | C-His |
| Biotinylated | no |
| Exact Sequence | Gly33-Gln325 |
| Molecular Weight | The protein has a predicted MW of 32.83 kDa. Due to glycosylation, the protein migrates to 35-45 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
IGF-CM102: Cynomolgus IGFBP2 Protein (IGF-CM102)
Insulin-like growth factor (IGF) binding protein 2 (IGFBP2) was discovered and identified as an IGF system regulator, controlling the distribution, function, and activity of IGFs in the pericellular space. IGFBP2 is a developmentally regulated gene that is highly expressed in embryonic and fetal tissues and markedly decreases after birth. Aberrant expression of IGFBP2 in cancer acts as a hub of an oncogenic network, integrating multiple cancer signaling pathways and serving as a potential therapeutic target for cancer treatment.
Please remember our product information: Cynomolgus IGFBP2 Protein (IGF-CM102) catalog number: IGF-CM102 KACTUS Biosystems